Arif GÜLKESEN, NEVZAT GÖZEL

Can number of platelets, blood red cell distribution, volume of neutrophil/lymphocyte ratio and mean platelet volume in patients with systemic lupus erythematosus and sjögren be used as an inflammation marker?

Sjögren’s syndrome (SS) and systemic lupus erythematosus (SLE) are autoimmune rheumatic diseases that can cause significant organ involvements. Hematological indices such as Platelet Count (PLT), Blood Red Cell Distribution Volume (RDW), Neutrophil/Lymphocyte Ratio (NLR), and Mean Platelet Volume (MPV) can be assessed by a simple haemogram test. These parameters may be related to the activity of the patient’s other diseases, such as cardiovascular diseases and inflammatory diseases. Our aim in this study is to demonstrate the possible association of hematologic markers such as PLT, RDW, NLR, MPV with the disease activity. 40 patients diagnosed with SS and 40 patients diagnosed with SLE followed in the physical medicine and rehabilitation and internal medicine rheumatology polyclinics and 40 healthy volunteers were included in the study. Laboratory findings were obtained from routine polyclinic controls. RDW, MPV, NLR ratios and platelet counts were calculated from the results of whole blood counts (CBC). RDW, MPV, NLR, and PLT were expressed as medians (minimum-maximum). Epidemiological data and RDW, MPV, NLR, PLT values of the cases included in the study were compared. Among the patients with SS and SLE, RDW, NLR and MPV values were higher than in the healthy control group. However, the elevation in the RDW was statistically significant while the height in the MPV and NLR was not statistically significant. Although studies with further patient participation are necessary, hematologic markers can be used in the diagnosis and follow-up of rheumatic diseases as they are both inexpensive and can be utilized extensively.

PDF

___

Hahn B H. Systemic lupus erythematosus and related syndromes. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, eds, Text-book of Rheumatology: WB Saunders Company. 1997;1015-56.

Rischmuller M, Tieu J, Lester S. Primary Sjögren’s Syndrome. Best Pract Res Clin Rheumatol. 2016;30:189-220.

Kısacık B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008;75:291-4.

Yazıcı S, Yazıcı M, Erer B, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010;21:122-5.

Mercan R, Bitik B, Tufan A, et al. The association between neutrophil/ lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal.

2016;30(5):597-601

Şafak S, Uslu AU, Serdal K, et al. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis. Afr Health Sci. 2014;14:919-4.

Qin B, Ma N, Tang Q, et al: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26:372-6

Soydinç S, Türkbeyler IH, Pehlivan Y, et al. Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis. Inflammation. 2014;37:100-6.

Canpolat F, Akpınar H, Eskioğlu F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol. 2010;29:325-8.

Açikgöz N, Karıncaoğlu Y, Ermiş N, et al. Increased mean platelet volume in Behcet’s disease with thrombotic tendency. Tohoku J Exp Med. 2010;221:119-23.

Rifaioğlu EN, Bülbül Şen B, Ekiz O, et al. Neutrophil to lymphocyte ratio in Behcet’s disease as a marker of disease activity. Acta Dermatovenerol Alp Pannonica Adriat. 2014;23:65-7.

Azab B, Torbey E, Singh J, et al: Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets. 2011;22:557-66.

Oehadian A, Suryadinata H, Dewi S, et al. The role of neutrophyl lymphocyte count ratio as an inflammatory marker in systemic lupus erythematosus. Acta Med Indones. 2013;45:170-4.

Yazıcı S, Yazıcı M, Erer B, et al. The platelet functions in patients with ankylosing spondylitis: anti-TNF-α therapy decreases the mean platelet volume and platelet mass. Platelets. 2010;21:126-31.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:17-25.

Masi AT. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.

Weichsler B, Davatchi F, Mizushima Y, et al. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335:1078-80.

Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8.

Zhi-De Hu, Yi Sun, Jie Guo, et al. Red blood cell distribution width and neutrophil/lymphocyte ratio are positively correlated with disease activity in primary Sjögren’s syndrome. Clinical Biochemistry. 2014;47:287-90.

F. Demircan F, Gözel N, Kılınç F, et al. The impact of red blood cell distribution width and neutrophil/lymphocyte ratio on the diagnosis of major depressive disorder. Neurol Ther. 2015;5:27-33.

Sun-Yi Chen, Juan Du, Xiao-Nian Lu, et al. Platelet distribution width as a novel indicator of disease activity in systemic lupus erythematosus. J Res Med Sci. 2018;23:48.